Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-25

Clinical Trial Update: Endoscopic and Microbiological Assessment of the Effect of Carvedilol Combined With Berberine on GOV in Cirrhosis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating endoscopic and microbiological effects of carvedilol combined with berberine on gastroesophageal varices in cirrhosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Berberine (berberine)
  • CARVEDILOL (Carvedilol)

Snippet

Sponsor: Tianjin Second People's Hospital | Conditions: Cirrhosis Due to Hepatitis B, Cirrhosis Due to Hepatitis C | Phase 3 | Status: UNKNOWN